MODELING THE COST-EFFECTIVENESS OF THE ALL ORAL, DIRECT-ACTING ANTIVIRAL REGIMEN DACLATASVIR PLUS SOFOSBUVIR IN PATIENTS CO-INFECTED WITH HEPATITIS C VIRUS (HCV) AND HIV

被引:3
作者
McEwan, P. [1 ]
Ward, T. [1 ]
Webster, S. [1 ]
Kalsekar, A. [2 ]
Brenner, M. [3 ]
Yuan, Y. [2 ]
机构
[1] Hlth Econ & Outcomes Res Ltd, Monmouth, Wales
[2] Bristol Myers Squibb Pharmaceut Ltd, Princeton, NJ USA
[3] Bristol Myers Squibb Pharmaceut Ltd, Uxbridge, Middx, England
关键词
D O I
10.1016/j.jval.2015.09.2213
中图分类号
F [经济];
学科分类号
02 ;
摘要
PGI32
引用
收藏
页码:A628 / A628
页数:1
相关论文
共 50 条
[21]   Cost-Effectiveness Analysis of Oral Direct-Acting Antivirals for Chinese Patients with Chronic Hepatitis C [J].
Pingyu Chen ;
Min Jin ;
Yang Cao ;
Hongchao Li .
Applied Health Economics and Health Policy, 2021, 19 :371-387
[22]   Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings [J].
Chen, Cheng-Pin ;
Cheng, Chien-Yu ;
Zou, Huachun ;
Cheng, Chun-Han ;
Cheng, Shu-Hsing ;
Chen, Cheng-Kuo ;
Chen, Ching-Hsiang ;
Bair, Ming-Jong .
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (04) :556-562
[23]   Characteristics and effectiveness in HCV mono-infected and HIV - HCV co-infected cirrhotic patients receiving oral direct-acting antiviral (DAA) regimens interferon-free therapies in southern Spain [J].
Alcaraz, Begona ;
Vera, Francisco ;
Escribano, Paloma ;
Rojano, Rocio ;
Jimeno, Amaya ;
Ruiz, Elena ;
Garcia, Ana ;
Trujillo, Javier ;
Cobos, Nazaret ;
Bernal, Enrique ;
Alcalde, Mar ;
Garcia, Josefina ;
Martinez, Onofre ;
Carolina Capozzi, Maria ;
Martinez, Lorena .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
[24]   Efficacy of sofosbuvir/velpatasvir/voxilaprevir in direct-acting antiviral experienced patients with hepatitis C virus [J].
Da, Ben L. ;
Lourdusamy, Vennis ;
Kushner, Tatyana ;
Dieterich, Douglas ;
Saberi, Behnam .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (06) :859-861
[25]   Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus [J].
Phil McEwan ;
Samantha Webster ;
Thomas Ward ;
Michael Brenner ;
Anupama Kalsekar ;
Yong Yuan .
Cost Effectiveness and Resource Allocation, 15
[26]   Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection [J].
Luisa Montes, Maria ;
Olveira, Antonio ;
Ahumada, Adriana ;
Aldamiz, Teresa ;
Garcia-Samaniego, Javier ;
Clemente, Ana ;
Berenguer, Juan ;
Gonzalez-Garcia, Juan ;
Martin-Carbonero, Luz .
AIDS, 2017, 31 (09) :1253-1260
[27]   Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals [J].
Hasson, Hamid ;
Merli, Marco ;
Messina, Emanuela ;
Bhoori, Sherrie ;
Salpietro, Stefania ;
Morsica, Giulia ;
Regalia, Enrico ;
Bagaglio, Sabrina ;
Lazzarin, Adriano ;
Uberti-Foppa, Caterina ;
Mazzaferro, Vincenzo .
JOURNAL OF HEPATOLOGY, 2017, 67 (02) :415-417
[28]   Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV) [J].
David R. Walker ;
Marcos C. Pedrosa ;
Shivaji R. Manthena ;
Nikil Patel ;
Steven E. Marx .
Advances in Therapy, 2015, 32 :1117-1127
[29]   Sofosbuvir-Velpatasvir With Ribavirin for 24 Weeks in Hepatitis C Virus Patients Previously Treated With a Direct-Acting Antiviral Regimen [J].
Gane, Edward J. ;
Shiffman, Mitchell L. ;
Etzkorn, Kyle ;
Morelli, Giuseppe ;
Stedman, Catherine A. M. ;
Davis, Mitchell N. ;
Hinestrosa, Federico ;
Dvory-Sobol, Hadas ;
Huang, K. C. ;
Osinusi, Anu ;
McNally, John ;
Brainard, Diana M. ;
McHutchison, John G. ;
Thompson, Alex J. ;
Sulkowski, Mark S. .
HEPATOLOGY, 2017, 66 (04) :1083-1089
[30]   Direct-Acting Antivirals in the Treatment of Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) Co-infected Patients: Real-Life Experience From Nepal [J].
Sudhamshu, K. C. ;
Karki, Niyanta ;
Sharma, Dilip ;
Khadka, Sandip ;
Tiwari, Pratap S. .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)